Brief Synopsis For this Briefing, we asked Prof. Ellen Heitzer and Georgios Vlachos from the Institute of Human Genetics, Medical University of Graz to share their experience in working with homologous recombination deficiency (HRD) testing. Join us to familiarize yourself with the...
Tissue and circulating tumor DNA testing can detect cancer alterations, but discrepancies in results can impact treatment decisions. This briefing discusses the basics and presents case studies.
Vessel Briefings are short sessions that are intended to not take too much time out of your busy schedule, but that still allow our community to interact on important topics.
Get the low down of what to expect during the program and how to engage with your peers.